| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $166.4M | $144.2M | $136.1M |
| YoY Revenue Growth % | +15.4% | +6.0% | — |
| Gross Profit | $29.9M | $34.9M | — |
| Gross Margin % | 18.0% | 24.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$108.5M | -$48.4M | -$14.2M |
| Operating Margin % | -65.2% | -33.6% | -10.4% |
| Net Income (GAAP) | -$104.8M | -$62.1M | -$25.4M |
| EBITDA (Normalized) | $7.2M | $17.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$60.9M | -$25.5M | -$15.4M |
| Capital Expenditures (CapEx) | $144.7M | $82.7M | — |
| Free Cash Flow (FCF) | -$205.6M | -$108.2M | -$15.4M |
| FCF Margin % | -80.0% | -75.0% | -11.3% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $491.3M | $55.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $383.7M | -$69.7M | — |